Forvis Mazars Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-20,131
| Closed | -$354K | – | 248 |
|
|
2017
Q3 | $354K | Sell |
20,131
-15,109
| -43% | -$266K | 0.04% | 168 |
|
|
2017
Q2 | $1.17M | Sell |
35,240
-2,075
| -6% | -$69K | 0.13% | 86 |
|
|
2017
Q1 | $1.2M | Buy |
37,315
+21,757
| +140% | +$698K | 0.15% | 76 |
|
|
2016
Q4 | $564K | Sell |
15,558
-9,440
| -38% | -$342K | 0.07% | 109 |
|
|
2016
Q3 | $1.15M | Buy |
24,998
+2,580
| +12% | +$119K | 0.16% | 73 |
|
|
2016
Q2 | $1.13M | Buy |
22,418
+1,678
| +8% | +$84.3K | 0.17% | 74 |
|
|
2016
Q1 | $1.11M | Buy |
20,740
+4,508
| +28% | +$241K | 0.18% | 69 |
|
|
2015
Q4 | $1.07M | Buy |
16,232
+3,160
| +24% | +$207K | 0.16% | 68 |
|
|
2015
Q3 | $738K | Sell |
13,072
-2,394
| -15% | -$135K | 0.13% | 79 |
|
|
2015
Q2 | $914K | Sell |
15,466
-406
| -3% | -$24K | 0.14% | 79 |
|
|
2015
Q1 | $989K | Sell |
15,872
-519
| -3% | -$32.3K | 0.14% | 80 |
|
|
2014
Q4 | $943K | Buy |
16,391
+551
| +3% | +$31.7K | 0.15% | 74 |
|
|
2014
Q3 | $851K | Buy |
15,840
+622
| +4% | +$33.4K | 0.15% | 76 |
|
|
2014
Q2 | $798K | Sell |
15,218
-1,381
| -8% | -$72.4K | 0.14% | 77 |
|
|
2014
Q1 | $878K | Sell |
16,599
-875
| -5% | -$46.3K | 0.16% | 83 |
|
|
2013
Q4 | $700K | Sell |
17,474
-3,181
| -15% | -$127K | 0.13% | 88 |
|
|
2013
Q3 | $780K | Buy |
20,655
+2,030
| +11% | +$76.7K | 0.16% | 84 |
|
|
2013
Q2 | $730K | Buy |
+18,625
| New | +$730K | 0.58% | 50 |
|